Provided by Tiger Fintech (Singapore) Pte. Ltd.

iRadimed

58.45
+0.47000.81%
Post-market: 58.450.00000.00%19:09 EDT
Volume:100.52K
Turnover:5.83M
Market Cap:743.20M
PE:37.72
High:59.01
Open:58.02
Low:57.64
Close:57.98
Loading ...

iRadimed sees FY25 EPS $1.71-$1.81.

TIPRANKS
·
13 Feb

IRadimed: Q4 Earnings Snapshot

Associated Press Finance
·
13 Feb

Iradimed Expects 2025 Revenue Of $78M-$82M Versus Consensus Of $80.66M, With Adjusted EPS Of $1.71-$1.81 Versus Consensus Of $1.75

Benzinga
·
13 Feb

IRadimed Corp: Increase in Quarterly Cash Dividend From $0.15 to $0.17 per Share

THOMSON REUTERS
·
13 Feb

IRadimed Corp Outlook 2025 Revenue $78.0 Mln to $82.0 Mln

THOMSON REUTERS
·
13 Feb

IRadimed Corp Outlook FY Adj EPS $1.71 to $1.81

THOMSON REUTERS
·
13 Feb

iRadimed Q4 2024 Adj EPS $0.44, Inline, Sales $19.39M Beat $19.14M Estimate

Benzinga
·
13 Feb

BRIEF-IRadimed Q4 EPS USD 0.4

Reuters
·
13 Feb

IRadimed Q4 EPS USD 0.4

THOMSON REUTERS
·
13 Feb

IRadimed Outlook Q1 Revenue USD 19.2-19.4 Million

THOMSON REUTERS
·
13 Feb

IRadimed Outlook Q1 EPS USD 0.35-0.39

THOMSON REUTERS
·
13 Feb

IRadimed Q4 Revenue USD 19.4 Million

THOMSON REUTERS
·
13 Feb

Waters (WAT) Q4 Earnings and Revenues Top Estimates

Zacks
·
12 Feb

IRadimed Corp expected to post earnings of 44 cents a share - Earnings Preview

Reuters
·
11 Feb

Lake Street Reaffirms Their Buy Rating on Iradimed (IRMD)

TIPRANKS
·
10 Feb

Three Undiscovered Gems in the US Stock Market

Simply Wall St.
·
06 Feb

IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025

GlobeNewswire
·
30 Jan

IRADIMED's (NASDAQ:IRMD) investors will be pleased with their solid 156% return over the last five years

Simply Wall St.
·
28 Jan

iRadimed reports preliminary Q4 revenue $19.2M-$19.4M

TIPRANKS
·
10 Jan

IRadimed Corp - Reports Prelim Q4 2024 Revenue in Range of $19.2M to $19.4M

THOMSON REUTERS
·
10 Jan